Binding of adiponectin and C1q in human serum, and clinical significance of the measurement of C1q–adiponectin / total adiponectin ratio
2013
Nakatsuji, Hideaki | Kobayashi, Hironori | Kishida, Ken | Nakagawa, Tohru | Takahashi, Shigeo | Tanaka, Hideaki | Akamatsu, Suguru | Funahashi, Tohru | Shimomura, Iichiro
OBJECTIVE: Adiponectin and C1q have similar sequences, exist abundantly in blood, and are produced by adipose tissues. The aim of this study was to examine whether adiponectin and C1q form protein-complex in blood and to know the clinical significance of the C1q–adiponectin (C1q–APN) complex in serum. METHODS: The direct interaction between adiponectin and C1q was investigated by far western blotting and co-immunoprecipitation. The relationship between serum C1q–APN and various clinical features was analyzed in 329 Japanese men who underwent health check-up, including measurements of visceral (VFA) and subcutaneous fat area (SFA) by computed tomography (Victor-J study). RESULTS: Adiponectin bound to C1q in vitro and C1q–APN complex existed in human blood. C1q–APN complexes were identified in high- and middle-molecular weight forms of adiponectin in human serum by gel-filtration chromatography. Stepwise multiple regression analysis identified body mass index, VFA and SFA as significant determinants of serum C1q–APN level. Serum C1q–APN/Total-APN ratio correlated positively with cardiovascular risk factor accumulation in subjects with VFA ≥100 cm². CONCLUSIONS: These results indicate that high- and middle-molecular forms of adiponectin partly consist of adiponectin-complex with other proteins including C1q and that the blood C1q–APN/Total-APN ratio may serve as a biomarker of the metabolic syndrome in general male subjects.
显示更多 [+] 显示较少 [-]